Cardiogenic shock: Therapy and prevention

17Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardiogenic shock is defined as profound circulatory failure resulting in insufficient tissue perfusion to meet resting metabolic demands. It occurs in approximately 7.5% of patients with acute myocardial infarction. Treatment strategies include inotropic agents, use of intra-aortic balloon counterpulsation, and revascularization. Current evidence supports the use of primary angioplasty. Surgery should be considered in patients with triple- vessel disease. If early catheterization is not available, thrombolytic therapy should be given to eligible patients and transfer to an interventional facility should be considered. Effective therapy for shock must also include a prevention strategy. This requires identification of patients at high risk for shock development and selection of patients who are candidates for aggressive intervention.

Cited by Powered by Scopus

Trends in cardiogenic shock: Report from the SHOCK study

114Citations
N/AReaders
Get full text

Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States

44Citations
N/AReaders
Get full text

TandemHeart as a Rescue Therapy for Patients With Critical Aortic Valve Stenosis

25Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Barry, W. L., & Sarembock, I. J. (1998). Cardiogenic shock: Therapy and prevention. Clinical Cardiology. John Wiley and Sons Inc. https://doi.org/10.1002/clc.4960210203

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

50%

PhD / Post grad / Masters / Doc 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

75%

Pharmacology, Toxicology and Pharmaceut... 1

25%

Save time finding and organizing research with Mendeley

Sign up for free